Ge Lou

457 total citations
13 papers, 373 citations indexed

About

Ge Lou is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ge Lou has authored 13 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Ge Lou's work include RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (3 papers) and Immunotherapy and Immune Responses (2 papers). Ge Lou is often cited by papers focused on RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (3 papers) and Immunotherapy and Immune Responses (2 papers). Ge Lou collaborates with scholars based in China. Ge Lou's co-authors include Fanling Meng, Xin Ge, Jin Zhang, Xiuwei Chen, Jing Gao, Yaoxian Wang, Hui Yu, Yunduo Liu, Shanshan Yang and Mingzhu Jin and has published in prestigious journals such as Biochemical Pharmacology, Experimental Cell Research and Journal of Cellular Biochemistry.

In The Last Decade

Ge Lou

13 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ge Lou China	11	260	81	64	63	54	13	373
Xuechi Lin China	10	216 0.8×	75 0.9×	40 0.6×	113 1.8×	55 1.0×	11	381
Seung Yeob Hyun South Korea	13	264 1.0×	82 1.0×	49 0.8×	80 1.3×	34 0.6×	14	371
Lixia Wang China	8	232 0.9×	55 0.7×	44 0.7×	112 1.8×	54 1.0×	11	388
Seung‐Ho Park South Korea	12	235 0.9×	92 1.1×	32 0.5×	109 1.7×	30 0.6×	19	341
Milena Mennecozzi Italy	12	245 0.9×	65 0.8×	31 0.5×	94 1.5×	93 1.7×	17	501
Shishi Tao Macao	7	241 0.9×	64 0.8×	70 1.1×	75 1.2×	77 1.4×	12	392
Bo-Ra Na South Korea	12	171 0.7×	52 0.6×	127 2.0×	36 0.6×	59 1.1×	17	397
Liza J. Burton United States	11	296 1.1×	161 2.0×	39 0.6×	138 2.2×	63 1.2×	13	472
Lang Bu China	12	208 0.8×	78 1.0×	97 1.5×	96 1.5×	25 0.5×	19	378

Countries citing papers authored by Ge Lou

Since Specialization

Citations

This map shows the geographic impact of Ge Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ge Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ge Lou more than expected).

Fields of papers citing papers by Ge Lou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ge Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ge Lou. The network helps show where Ge Lou may publish in the future.

Co-authorship network of co-authors of Ge Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Ge Lou. A scholar is included among the top collaborators of Ge Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ge Lou. Ge Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Pi, Yanan, Bairong Xia, Mingzhu Jin, Weilin Jin, & Ge Lou. (2021). Exosomes: Powerful weapon for cancer nano-immunoengineering. Biochemical Pharmacology. 186. 114487–114487. 30 indexed citations

Ge, Tingting, Tianbo Liu, Liyuan Guo, Zhuo Chen, & Ge Lou. (2020). MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma. Experimental Cell Research. 396(1). 112241–112241. 17 indexed citations

Luo, Kangjia, Jingjing Ji, Ge Lou, et al.. (2019). Fusobacterium nucleatum, the communication with colorectal cancer. Biomedicine & Pharmacotherapy. 116(13). 108988–108988. 28 indexed citations

Li, Bing, Wei Huang, Ning Cao, & Ge Lou. (2018). Forkhead‐box R2 promotes metastasis and growth by stimulating angiogenesis and activating hedgehog signaling pathway in ovarian cancer. Journal of Cellular Biochemistry. 119(9). 7780–7789. 15 indexed citations

Cheng, Hairong, et al.. (2016). Synergism between RIZ1 gene therapy and paclitaxel in SiHa cervical cancer cells. Cancer Gene Therapy. 23(11). 392–395. 8 indexed citations

Meng, Fanling, Xiuwei Chen, Hongtao Song, & Ge Lou. (2015). LAPTM4B Down Regulation Inhibits the Proliferation, Invasion and Angiogenesis of HeLa Cells In Vitro. Cellular Physiology and Biochemistry. 37(3). 890–900. 25 indexed citations

Wang, Yaoxian, Hui Yu, Jin Zhang, et al.. (2015). Hesperidin inhibits HeLa cell proliferation through apoptosis mediated by endoplasmic reticulum stress pathways and cell cycle arrest. BMC Cancer. 15(1). 682–682. 82 indexed citations

Hou, Yan, Junnan Li, Hongyu Xie, et al.. (2015). Differential plasma lipids profiling and lipid signatures as biomarkers in the early diagnosis of ovarian carcinoma using UPLC-MS. Metabolomics. 12(2). 20 indexed citations

Liu, Yunduo, et al.. (2013). Clinical Significance of Yes-Associated Protein Overexpression in Cervical Carcinoma. International Journal of Gynecological Cancer. 23(4). 735–742. 36 indexed citations

10.

Yin, Mingzhu, Cong Li, Xia Li, et al.. (2011). Over‐expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer. Journal of Surgical Oncology. 104(1). 29–36. 46 indexed citations

11.

Cheng, Haiyan, Xiuwei Chen, Cheng Li, Yunduo Liu, & Ge Lou. (2010). DNA methylation and carcinogenesis of PRDM5 in cervical cancer. Journal of Cancer Research and Clinical Oncology. 136(12). 1821–1825. 20 indexed citations

12.

Lou, Ge, et al.. (2009). CHFR promoter hypermethylation and reduced CHFR mRNA expression in ovarian cancer. The International Journal of Biological Markers. 24(2). 83–89. 6 indexed citations

13.

Tao, Qun, Ge Lou, Mei Bai, et al.. (2001). Interleukin 18 transfection enhances antitumor immunity induced by dendritic cell-tumor cell conjugates.. PubMed. 61(9). 3735–40. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact